Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI
New England Journal of Medicine · 23.01.2025 · 392 (4) · 400-403
DOI: 10.1056/nejme2414209 ↗Kurz gefasst
Editorial in der Zeitschrift New England Journal of Medicine, erschienen am 23.01.2025. Verfasst von Dominick J Angiolillo und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the University of Florida College of Medicine, Jacksonville (D.J.A.); and Azienda Ospedaliero-Universitaria Policlinico "Gaspare Rodolico-San Ma…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
This editorial describes the science behind a clinical trial reported by Ruff et al. in which a monoclonal antibody targeting factors XI and XIa was evaluated for its effects on bleeding events in patients with atrial fibrillation.
Autor:innen und Institutionen
- From the University of Florida College of Medicine, Jacksonville (D.J.A.); and Azienda Ospedaliero-Universitaria Policlinico "Gaspare Rodolico-San Marco," University of Catania, Catania, Italy (D.C.).
Zitieren
APA
Angiolillo, D. J., & Capodanno, D. (2025). Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI. New England Journal of Medicine, 392(4), 400-403. https://doi.org/10.1056/nejme2414209
Vancouver
Angiolillo DJ, Capodanno D. Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI. New England Journal of Medicine. 2025;392(4):400-403. doi:10.1056/nejme2414209
BibTeX
@article{Angiolillo2025,
author = {Angiolillo, Dominick J and Capodanno, Davide},
title = {Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {4},
pages = {400--403},
doi = {10.1056/nejme2414209}
}
EUVIMED